Skip to content

ABT

Abbott Laboratories

EBITDA, 2025
$11.2B
YoY, 2025
+11.2%
5-year CAGR
+5.2%
10-year CAGR
+9.9%

EBITDA

EBITDA by fiscal year

PeriodEBITDAYoY
2025$11.2B+11.2%
2024$10.0B+3.3%
2023$9.7B−16.4%
2022$11.6B−2.8%
2021$12.0B+37.8%
2020$8.7B+15.1%
2019$7.5B+8.9%
2018$6.9B+51.1%
2017$4.6B+4.7%
2016$4.4B+0.9%
2015$4.3B+4.6%
2014$4.1B+7.7%
2013$3.9B−7.0%
2012$4.1B−11.4%
2011$4.7B−46.4%
2010$8.7B+4.6%
2009$8.3B+10.5%
2008$7.5B+17.1%
2007$6.4B—